Journal
NATURE REVIEWS CANCER
Volume 20, Issue 7, Pages 383-397Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41568-020-0256-z
Keywords
-
Categories
Funding
- Jane Coffin Childs Memorial Fund for Medical Research
- Thrasher Research Fund Early Career Award programme
- University of California, San Francisco Program for Breakthrough Biomedical Research Independent Postdoctoral Research Fellow
- NIH/NCI [R35CA197709-01]
Ask authors/readers for more resources
This Review discusses oncoproteins known to cause both cancer and congenital disorders, and the biology of oncoproteins in both transformed and untransformed tissues, exploring the fundamentals of genetics, signalling and the pathogenesis that underlie oncoprotein duality. Human oncoproteins promote transformation of cells into tumours by dysregulating the signalling pathways that are involved in cell growth, proliferation and death. Although oncoproteins were discovered many years ago and have been widely studied in the context of cancer, the recent use of high-throughput sequencing techniques has led to the identification of cancer-associated mutations in other conditions, including many congenital disorders. These syndromes offer an opportunity to study oncoprotein signalling and its biology in the absence of additional driver or passenger mutations, as a result of their monogenic nature. Moreover, their expression in multiple tissue lineages provides insight into the biology of the proto-oncoprotein at the physiological level, in both transformed and unaffected tissues. Given the recent paradigm shift in regard to how oncoproteins promote transformation, we review the fundamentals of genetics, signalling and pathogenesis underlying oncoprotein duality.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available